{"document_type": "article", "byline": {"person": [{"role": "reported", "firstname": "Robert", "organization": "", "rank": 1, "lastname": "CYRAN"}], "original": "By ROBERT CYRAN"}, "news_desk": "Business", "slideshow_credits": null, "abstract": null, "multimedia": [], "headline": {"kicker": "Breakingviews", "content_kicker": "Breakingviews", "main": "Finger-Pointing Abounds in Failed Pfizer Deal"}, "print_page": null, "keywords": [{"value": "Pfizer Inc", "is_major": "N", "rank": "1", "name": "organizations"}, {"value": "ALLERGAN INC", "is_major": "N", "rank": "2", "name": "organizations"}, {"value": "Treasury Department", "is_major": "N", "rank": "3", "name": "organizations"}, {"value": "Read, Ian C", "is_major": "N", "rank": "4", "name": "persons"}, {"value": "Mergers, Acquisitions and Divestitures", "is_major": "N", "rank": "5", "name": "subject"}, {"value": "Taxation", "is_major": "N", "rank": "6", "name": "subject"}], "snippet": "In the abandoned merger with Allergan, lawmakers, the Treasury Department and Pfizer itself bear some responsibility.", "source": "The New York Times", "lead_paragraph": "In the abandoned merger with Allergan, lawmakers, the Treasury Department and Pfizer itself bear some responsibility.", "word_count": "366", "pub_date": "2016-04-07T00:00:00Z", "subsection_name": "DealBook", "blog": [], "type_of_material": "News", "section_name": "Business Day", "web_url": "http://www.nytimes.com/2016/04/07/business/dealbook/finger-pointing-abounds-in-failed-pfizer-deal.html", "_id": "5705613738f0d86865ca51da"}